TY - JOUR
T1 - Personalized respiratory medicine: Exploring the horizon, addressing the issues: Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014
AU - Agustí, Alvar
AU - Antó, Josep Maria
AU - Auffray, Charles
AU - Barbé, Ferran
AU - Barreiro, Esther
AU - Dorca, Jordi
AU - Escarrabill, Joan
AU - Faner, Rosa
AU - Furlong, Laura I.
AU - Garcia-Aymerich, Judith
AU - Gea, Joaquim
AU - Lindmark, Bertil
AU - Monsó, Eduard
AU - Plaza, Vicente
AU - Puhan, Milo A.
AU - Roca, Josep
AU - Ruiz-Manzano, Juan
AU - Sampietro-Colom, Laura
AU - Sanz, Ferran
AU - Serrano, Luis
AU - Sharpe, James
AU - Sibila, Oriol
AU - Silverman, Edwin K.
AU - Sterk, Peter J.
AU - Sznajder, Jacob I.
PY - 2015/2/15
Y1 - 2015/2/15
N2 - Copyright © 2015 by the American Thoracic Society. This Pulmonary Perspective summarizes the content and main conclusions of an international workshop on personalized respiratory medicine coorganized by the Barcelona Respiratory Network (www.brn.cat) and the AJRCCM in June 2014. It discusses (1) its definition and historical, social, legal, and ethical aspects; (2) the view from different disciplines, including basic science, epidemiology, bioinformatics, and network/systems medicine; (3) the bottlenecks and opportunities identified by some currently ongoing projects; and (4) the implications for the individual, the healthcare system and the pharmaceutical industry. The authors hope that, although it is not a systematic review on the subject, this document can be a useful reference for researchers, clinicians, healthcare managers, policy-makers, and industry parties interested in personalized respiratory medicine.
AB - Copyright © 2015 by the American Thoracic Society. This Pulmonary Perspective summarizes the content and main conclusions of an international workshop on personalized respiratory medicine coorganized by the Barcelona Respiratory Network (www.brn.cat) and the AJRCCM in June 2014. It discusses (1) its definition and historical, social, legal, and ethical aspects; (2) the view from different disciplines, including basic science, epidemiology, bioinformatics, and network/systems medicine; (3) the bottlenecks and opportunities identified by some currently ongoing projects; and (4) the implications for the individual, the healthcare system and the pharmaceutical industry. The authors hope that, although it is not a systematic review on the subject, this document can be a useful reference for researchers, clinicians, healthcare managers, policy-makers, and industry parties interested in personalized respiratory medicine.
U2 - 10.1164/rccm.201410-1935PP
DO - 10.1164/rccm.201410-1935PP
M3 - Review article
VL - 191
SP - 391
EP - 401
IS - 4
ER -